ALEMBIC PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Quarterly Results    (APLL)

Here are the latest quarterly results of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA financial fact sheet and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

ALEMBIC PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m12,09112,06813,41314,57113,14312,80413,26012,923 
Other income Rs m4933225401922 
Turnover Rs m12,09512,07713,41614,60313,16912,84313,27912,945 
Expenses Rs m8,8418,7939,34010,1379,4929,38710,90110,351 
Gross profit Rs m3,2513,1674,0744,4343,6513,4172,3592,572 
Depreciation Rs m418441415438470512532546 
Interest Rs m7478674523262146 
Profit before tax Rs m2,7632,6573,5953,9843,1832,9191,8262,003 
Tax Rs m486621668730591545342395 
Profit after tax Rs m2,2772,0352,9273,2542,5922,3741,4841,607 
Gross profit margin %26.926.230.430.427.826.717.819.9 
Effective tax rate %17.623.418.618.318.618.718.719.7 
Net profit margin %18.816.921.822.319.718.511.212.4 
Diluted EPS Rs 11.6 10.4 14.9 16.6 13.2 12.1 7.5 8.2  
Diluted EPS (TTM) Rs NA 40.7 49.6 53.4 55.0 56.7 49.4 41.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: ALEMBIC PHARMA 3QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SUN PHARMA    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    

Compare ALEMBIC PHARMA With:   SUN PHARMA    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Views on news

ALEMBIC PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of ALEMBIC PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

4 'Digital India' Stocks to Add to Your 2022 Watchlist (Views On News)

Jan 28, 2022

Digitisation is touching every aspect of our lives. As this megatrend picks up pace, there will be companies benefitting from it for years to come.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here... (Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 28, 2022 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - TEVA PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS